Stephen R. Biggar, Ph.D.

Stephen R. Biggar, Ph.D.

Chair of the BoardatAcadia Pharmaceuticals· In proxies 2023–2025

Stephen R. Biggar, Ph.D. sits on 7 public boards.

Boards1

  • Kiniksa Pharmaceuticals InternationalDirector · 9 yr on the boardIndependentNominating and Corporate Governance (Chair), Science and Research—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Acadia PharmaceuticalsPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrStock in role +33%
    • Director2024 – Present · 2 yrNo stock prices for these years
  2. TScan Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Castle BiosciencesPublic company
    • Director? – PresentNo stock prices for these years
  4. Kiniksa Pharmaceuticals, Ltd.Public company
    • Director? – PresentNo stock prices for these years
  5. Notch Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. TrusteesPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?